References
- Adelstein DJ, Tomashefski JF, Jr, Snow NJ, et al (1986). Mixed small cell and non-small cell lung cancer. Chest, 89, 699- 704. https://doi.org/10.1378/chest.89.5.699
- Baldini E, Tibaldi C, Chella A, et al (1996). Phase II study of Vinorelbine/ ifosfamide/Cisplatin for the treatment of advanced non-small cell lung cancer. Ann Oncol, 7, 747-9. https://doi.org/10.1093/oxfordjournals.annonc.a010726
- Barone C, Corsi DC, Pozzo C, et al (2000). Vinorelbine and alternating Cisplatin and ifosfamide in the treatment of nonsmall cell lung cancer. Oncology, 58, 25-30. https://doi.org/10.1159/000012075
- Gottfried M, Ramlau R, Krzakowski M, et al (2008). Cisplatinbased three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results. J Thorac Oncol, 3, 152-7. https://doi.org/10.1097/JTO.0b013e318160c0e7
- Mangum MD, Greco FA, Hainsworth JD, et al (1989). Combined small-cell and non-small-cell lung cancer. J Clin Oncol, 7, 607-12.
- Montalar J, Morales S, Maestu I, et al (2001). Vinorelbine, ifosfamide and Cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer. Lung Cancer, 34, 305-11. https://doi.org/10.1016/S0169-5002(01)00255-0
- Nicholson SA, Beasley MB, Brambilla E, et al (2002). Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol, 26, 1184-97. https://doi.org/10.1097/00000478-200209000-00009
- Radice PA, Matthews MJ, Ihde DC, et al (1982). The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer, 50, 2894-902. https://doi.org/10.1002/1097-0142(19821215)50:12<2894::AID-CNCR2820501232>3.0.CO;2-G
- Rey F, Astoul P, Marqueste L, et al (1998). Cisplatin, ifosfamide and Vinorelbine combination chemotherapy in stage III-IV non-small cell lung cancer-a phase II study. Am J Oncol, 21, 518-22. https://doi.org/10.1097/00000421-199810000-00021
- Souquet PJ, Fournel P, Bohas CH, et al (1996). Cisplatin and ifosfamide with various doses of Vinorelbine (Navelbine(R)) in advanced non-small cell lung cancer. Semin Oncol, 23, 8-10.
- Souquet PJ, Tan EH, Rodrigues Pereira J, et al (2002). GLOB-1: a prospective randomised clinical phase III trial comparing Vinorelbine - Cisplatin with Vinorelbine - Ifosfamide - Cisplatin in metastatic non-small-cell lung cancer patients. Ann Oncol, 13, 1853-61. https://doi.org/10.1093/annonc/mdf316
- Tan EH, Ang PT, Wee J, et al (1999). Vinorelbine, Ifosfamide and Cisplatin in advanced non-small cell lung cancer. Acta Oncol, 38, 619-22. https://doi.org/10.1080/028418699431212
- Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumours. IARC Press, France.
- Song SY, Kim WS, Kim K, et al (2003). Vinorelbine, Ifosfamide, ND Cisplatin Combination as Salvage Chemotherapy in advanced Non-small cell lung cancer. Jpn J Clin Oncol, 33, 509-13. https://doi.org/10.1093/jjco/hyg100
Cited by
- ) and Paclitaxel for Treatment of Patients with Metastatic Gastric Cancer vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2591
- Chemotherapy and Late Course Three Dimensional Conformal Radiotherapy for Treatment of Patients with Stage III Non-small Cell Lung Cancer vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2663
- Etoposide-Cisplatin Alternating with Vinorelbine-Cisplatin Versus Etoposide-Cisplatin Alone in Patients with Extensive Disease Combined with Small Cell Lung Cancer vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4159
- Adoptive Immunotherapy for Small Cell Lung Cancer by Expanded Activated Autologous Lymphocytes: a Retrospective Clinical Analysis vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1487